|4Dec 26, 1:09 PM ET

Lemerond Nicole 4

4 · InMed Pharmaceuticals Inc. · Filed Dec 26, 2023

Insider Transaction Report

Form 4
Period: 2023-12-23
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-12-23+7,1008,500 total
    Exercise: $0.37Exp: 2028-12-22Common shares (7,100 underlying)
Footnotes (1)
  • [F1]The options were granted on 12/23/2023 and will vest 100% on the one-year anniversary of the grant date (December 23, 2024) or immediately prior to the next Annual General Meeting, whichever is sooner.

Documents

1 file
  • 4
    ownership.xmlPrimary